Frederick Hrkac - 12 May 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Director
Signature
/s/ Frederick Hrkac
Issuer symbol
BSGM
Transactions as of
12 May 2022
Net transactions value
$0
Form type
4
Filing time
21 Jun 2022, 17:01:33 UTC
Previous filing
21 Jun 2022
Next filing
22 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 12 May 2022 Common Stock 50,000 $0.8200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares underlying this stock option vested and became exercisable immediately on the date of grant and 50% will vest and become exercisable on the first anniversary of the date of the director appointment on April 28, 2022, provided Mr. Hrkac is still serving as a director on such date and subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.